UPDATE : Monday, February 17, 2020
상단여백
Hana says US Cosmo submits new drug application for Remimazolam by Lee Han-soo 2019-04-10 17:51
WHO grants PQ certification to SK Bioscience’s trivalent flu shot by Lee Han-soo 2019-04-10 12:52
'MSD’s monitoring scheme damaged doctors’ trust in drugmaker’ by Choi Gwang-seok 2019-04-10 11:49
CrystalGenomics to expand export accord with PharmArtis by Lee Han-soo 2019-04-09 18:14
Bukwang to start P2 trials dyskinesia treatment in Europe by Lee Han-soo 2019-04-09 17:31
라인
Biogen’s orphan drug Spinraza to get reimbursement by Lee Han-soo 2019-04-09 15:50
Peripheral neuropathy reported in liver cancer drug Stivarga by Lee Hye-seon 2019-04-09 15:25
Hanmi, Enzychem challenge Amgen in neutropenia treatment by Jeong Sae-im 2019-04-09 12:15
Kolon confirms cancerous cell lines in Invossa by Lee Han-soo 2019-04-09 11:16
Dong-A ST’s investigational drug posts positive study results by Jeong Sae-im 2019-04-08 16:00
라인
Saxenda no silver bullet for weight loss, doctors warn by Kim Yun-mi 2019-04-05 16:21
ISU Abxis’ US partner to start P2b trials of hemophilia B treatment by Lee Han-soo 2019-04-05 16:16
Gemvax & Kael’s wins nod for P3 trial of benign prostatic hyperplasia treatment by Lee Han-soo 2019-04-05 14:49
Handok, CMG apply for P1 trial for anticancer treatment candidate by Lee Han-soo 2019-04-05 12:23
Court suspends ministry’s disciplinary action against Dong-A ST by Lee Han-soo 2019-04-04 16:55
라인
Corestem’s Lou Gehrig disease treatment becomes orphan drug in EU by Lee Han-soo 2019-04-04 15:25
Genexine, NeoImmuneTech release 2 clinical trial results at AACR by Lee Han-soo 2019-04-04 14:16
GC, Clinigen K.K. ink licensing accord for Hunter syndrome drug by Lee Han-soo 2019-04-04 11:19
Fate of Kolon Life Science hangs on Invossa-K test results by Lee Hye-seon 2019-04-03 18:14
[Special] MSD Korea makes wrong excuse on external monitoring by Jeong Sae-im 2019-04-03 16:59
여백
여백
여백
Back to Top